Vimarsana
Biggest News Aggregation in the World

Branded Generics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Branded Generics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Branded Generics Today - Breaking & Trending Today

Ursodeoxycholic Acid Market size is set to grow by USD 358.41 million from 2023-2027, rise in number of liver transplants boost the market, Technavio - Vimarsana News

Ursodeoxycholic Acid Market size is set to grow by USD 358.41 million from 2023-2027, rise in number of liver transplants boost the market, Technavio

/PRNewswire/ -- The global ursodeoxycholic acid market size is estimated to grow by USD 358.41 million from 2023-2027, according to Technavio. The market is...

Global Branded Generics Industry Set to Reach US$747.2 Million by 2033 with an Impressive 8.6% CAGR - Vimarsana News

Global Branded Generics Industry Set to Reach US$747.2 Million by 2033 with an Impressive 8.6% CAGR

The Global Branded Generics Industry is on the cusp of remarkable growth, with a projected value of US$ 327.8 million in 2023. Projections reveal an impressive growth trajectory, soaring to US$ 747.2 million by 2033, bolstered by a noteworthy Compound Annual Growth Rate (CAGR) of 8.6%.This upsurge can be attributed...

Global Branded Generics Market to Reach $464.58 Billion by - Vimarsana News

Global Branded Generics Market to Reach $464.58 Billion by

Dublin, July 14, 2023 (GLOBE NEWSWIRE) -- The "Branded Generics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. ...

United States Generic Drugs Market Report 2023-2028 Featuring Major Players - Teva Pharma, Aurobindo Pharma, Sun Pharma, Abbott Laboratories, Lupin Pharmaceuticals, Viatris, Sandoz, & Dr. Reddy's - Vimarsana News

United States Generic Drugs Market Report 2023-2028 Featuring Major Players - Teva Pharma, Aurobindo Pharma, Sun Pharma, Abbott Laboratories, Lupin Pharmaceuticals, Viatris, Sandoz, & Dr. Reddy's

/PRNewswire/ -- The "United States Generic Drugs Market, Forecast 2023-2028, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis" report...

Ajanta Pharma hits 52-week high on upbeat branded generic business outlook - Vimarsana News

Ajanta Pharma hits 52-week high on upbeat branded generic business outlook

The management is confident to scale up margins again in the coming years on the back of enhanced contribution from Branded Generics business and normalisation of freight costs